BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1248188)

  • 1. The use of heparin in the treatment of idiopathic rapidly progressive glomerulonephritis.
    Suc JM; Durand D; Conte J; Mignon-Conte M; Orfila C; That HT; Duchet JP
    Clin Nephrol; 1976 Jan; 5(1):9-13. PubMed ID: 1248188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dosage heparin in rapidly progressive glomerulonephritis.
    Fye KH; Hancock D; Moutsopoulos H; Humes HD; Arieff AI
    Arch Intern Med; 1976 Sep; 136(9):995-9. PubMed ID: 962457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Attempt at heparin therapy for rapidly progressing idiopathic glomerulonephritis].
    Suc JM; Durand D; Conte J; Mignon-Conte M; Orfila C; Ton That HT; Duchet JP
    J Urol Nephrol (Paris); 1975; 81(4-5):291-8. PubMed ID: 1159888
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
    Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal sclerosing glomerulonephritis: a kinetic evaluation of hemostasis and the effect of anticoagulant therapy: a controlled study.
    Futrakul P; Poshyachinda M; Mitrakul C
    Clin Nephrol; 1978 Nov; 10(5):180-6. PubMed ID: 729213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of dense deposits in Type II membranoproliferative glomerulonephritis: case report of clinical course in a child.
    Kher KK; Makker SP; Aikawa M; Kirson IJ
    Clin Nephrol; 1982 Feb; 17(2):100-3. PubMed ID: 7067166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible acute anuric lupus nephritis.
    Ponticelli C; Imbasciati E; Brancaccio D; Tarantino A; Rivolta E
    Proc Eur Dial Transplant Assoc; 1975; 11():500-5. PubMed ID: 1197273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current trends in the treatment of chronic glomerulonephritis].
    Belovezhdov N; Altŭnkova I; Neshev Kh; Robeva R; Gruev I
    Vutr Boles; 1981; 20(5):54-64. PubMed ID: 7324454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Further study of the indications for combination cytostatic-anticoagulant-antiaggregation-corticosteroid therapy of chronic glomerulonephritis].
    Ratner MIa; Tomilina NA; Biriukova LS; Monchakovskiĭ SF
    Ter Arkh; 1985; 57(6):69-74. PubMed ID: 4071418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Controlled therapeutic trial in IgA glomerulonephritis].
    Belovezhdov N; Robeva R
    Vutr Boles; 1982; 21(3):49-53. PubMed ID: 7051564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is it justifiable to use antiplatelet drugs as a universal protection in patients with chronic glomerular damage?].
    Duclos J
    Rev Med Chil; 1993 Mar; 121(3):286-91. PubMed ID: 8248641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapidly progressive glomerulonephritis treated with anticoagulants.
    Arieff AI; Pinggera WF
    Arch Intern Med; 1972 Jan; 129(1):77-84. PubMed ID: 4550298
    [No Abstract]   [Full Text] [Related]  

  • 13. [Glomerulonephritis therapy. Immunosuppression or coagulation inhibitors - a comparison].
    Schmitt E; Sinn W; Lakner V; Ratner M; Tomilina N
    Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 45-8. PubMed ID: 7467565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are anticoagulants beneficial in the treatment of rapidly progressive glomerulonephritis?
    Cameron JS
    Proc Eur Dial Transplant Assoc; 1973; 10(0):57-90. PubMed ID: 4606240
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapidly progressive glomerulonephritis with extensive glomerular crescent formation.
    Neild GH; Cameron JS; Ogg CS; Turner DR; Williams DG; Brown CB; Chantler C; Hicks J
    Q J Med; 1983; 52(207):395-416. PubMed ID: 6647750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy.
    Bergstein J; Leiser J; Andreoli SP
    Clin Nephrol; 1998 Jan; 49(1):9-14. PubMed ID: 9491279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
    Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berger's disease in children. Natural history and outcome.
    Lévy M; Gonzalez-Burchard G; Broyer M; Dommergues JP; Foulard M; Sorez JP; Habib R
    Medicine (Baltimore); 1985 May; 64(3):157-80. PubMed ID: 3887094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery from rapidly progressive glomerulonephritis. Improvement after plasmapheresis and immunosuppression.
    Warren SE; Mitas JA; Golbus SM; Swerdlin AR; Cohen IM; Cronin RE
    Arch Intern Med; 1981 Feb; 141(2):175-80. PubMed ID: 7006545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of primary glomerulonephritis. Comparative study on the effect of cytostatics-prednisone and cytostatics-anticoagulant-aggregation inhibitor combination].
    Schmitt E; Kröger E; Lakner V; Klinkmann H; Ratner M; Tomilina N
    Z Gesamte Inn Med; 1979 Sep; 34(17):465-71. PubMed ID: 539014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.